Which has the lower trailing P/E, NVO or PFE?

NVO has the lower trailing P/E: NVO trades at 10.48 and PFE at 36.40. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, NVO or PFE?

Over the past five years, NVO grew revenue faster — NVO at a 19.76% CAGR versus PFE at 6.29%.

Does NVO or PFE pay a bigger dividend?

NVO yields 4.17% and PFE yields 6.20% based on trailing dividends and the latest price.

Is NVO or PFE more profitable?

NVO runs the higher net margin — NVO at 35.33% versus PFE at 6.81%.

How have NVO and PFE total returns compared?

Over the past 10 years, NVO delivered 9.46% and PFE delivered 3.15% annualized total return. Past performance doesn't predict future results.

Novo Nordisk A/S (NVO) vs Pfizer Inc. (PFE)

A side-by-side comparison of Novo Nordisk A/S and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

NVO

Novo Nordisk A/S

$188.86B

$42.53HealthcareDelayed quote: Sep 15, 2026, 4:00 PM EDT

PFE

Pfizer Inc.

$157.02B

$27.55HealthcareDelayed quote: Sep 15, 2026, 4:02 PM EDT

Total return — NVO vs PFE

growth of $100 · dividends reinvested · last 10y

NVO +135.8% (+9.0%/yr)PFE +37.0% (+3.2%/yr)NVO compounded faster over this window

NVO PFE

NVO vs PFE: by the numbers

•NVO is the larger company ($188.86B vs $157.02B market cap).
•NVO trades at the lower trailing earnings multiple (10.48 vs 36.40 P/E), one valuation lens rather than an overall verdict.
•NVO converts more revenue to profit (35.33% vs 6.81% net margin).
•NVO grew revenue faster over the past five years (19.76% vs 6.29% CAGR).
•PFE pays the higher dividend yield (6.20% vs 4.17%).

Metrics side by side

Valuation

Metric	NVO	PFE
P/E ratio	10.48	36.40
Forward P/E	N/A	9.26
P/S ratio	3.70	2.47
P/B ratio	5.60	1.84
EV / EBITDA	7.76	10.11
FCF yield	3.94%	7.00%

Profitability

Metric	NVO	PFE
Gross margin	80.64%	71.32%
Operating margin	43.10%	25.08%
Net margin	35.33%	6.81%
ROE	53.50%	5.09%
ROIC	30.21%	9.33%

Dividends

Metric	NVO	PFE
Dividend yield	4.17%	6.20%
Payout ratio	44.27%	227.27%

Growth (annualized)

Metric	NVO	PFE
Revenue CAGR (5Y)	19.76%	6.29%
EPS CAGR (5Y)	19.59%	-3.78%
FCF CAGR (5Y)	-1.45%	-3.11%
Total return CAGR (5Y)	-0.65%	-4.53%

Frequently asked

Which has the lower trailing P/E, NVO or PFE?: NVO has the lower trailing P/E: NVO trades at 10.48 and PFE at 36.40. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, NVO or PFE?: Over the past five years, NVO grew revenue faster — NVO at a 19.76% CAGR versus PFE at 6.29%.
Does NVO or PFE pay a bigger dividend?: NVO yields 4.17% and PFE yields 6.20% based on trailing dividends and the latest price.
Is NVO or PFE more profitable?: NVO runs the higher net margin — NVO at 35.33% versus PFE at 6.81%.
How have NVO and PFE total returns compared?: Over the past 10 years, NVO delivered 9.46% and PFE delivered 3.15% annualized total return. Past performance doesn't predict future results.

Go deeper

Full NVO analysis Full PFE analysis Interactive comparison tool

Dig into the metrics

Novo Nordisk A/S P/E ratio Pfizer P/E ratio Novo Nordisk A/S dividend yield Pfizer dividend yield Novo Nordisk A/S ROE Pfizer ROE Novo Nordisk A/S operating margin Pfizer operating margin Novo Nordisk A/S revenue growth Pfizer revenue growth Novo Nordisk A/S free cash flow Pfizer free cash flow

Novo Nordisk A/S & Pfizer appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.